Anders Björk
NRG Oncology(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Neurotransmitter Receptor Influence on Behavior, Angiogenesis and VEGF in Cancer, Prostate Cancer Treatment and Research, Cancer therapeutics and mechanisms
Most-Cited Works
- → Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides(2009)357 cited
- → Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer(2011)208 cited
- → Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure−Activity Relationship(2004)157 cited
- → Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors(2010)90 cited
- → Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer(2006)87 cited
- → Effects of amperozide in schizophrenia(1991)59 cited
- → Is social stress in pigs a detrimental factor to health and growth that can be avoided by amperozide treatment?(1989)40 cited
- → Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats(1993)38 cited
- → Inhibition of Autoimmune Disease by the Immunomodulator Linomide Correlates with the Ability to Activate Macrophages(2000)20 cited
- → Development of a Practical and Reliable Synthesis of Laquinimod(2007)9 cited